A trial of Ro 03-8799 (pimonidazole) in carcinoma of the uterine cervix: an interim report from the Medical Research Council Working Party on advanced carcinoma of the cervix
- 1 February 1993
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 26 (2) , 93-103
- https://doi.org/10.1016/0167-8140(93)90089-q
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Applying Bayesian ideas in drug development and clinical trialsStatistics in Medicine, 1993
- Tumor blood flow changes induced by chemical modifiers of radiation responseInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Improving the quality of data in clinical trials in cancerBritish Journal of Cancer, 1991
- Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervixInternational Journal of Radiation Oncology*Biology*Physics, 1989
- A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervixAmerican Journal of Obstetrics and Gynecology, 1988
- Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: Preliminary report of a radiation therapy oncology group randomized trialInternational Journal of Radiation Oncology*Biology*Physics, 1987
- New prognostic factors in squamous cell carcinoma of cervix uteriAmerican Journal of Clinical Oncology, 1985
- The Medical Research Council trial of misonidazole in carcinoma of the uterine cervixThe British Journal of Radiology, 1984
- Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the cervixThe British Journal of Radiology, 1978
- Clinical testing of the radiosensitiser Ro-07-0582 I. dose tolerance, serum and tumour concentrationsClinical Radiology, 1976